Latest
Research, clinical trials, regulatory updates, and industry analysis from the longevity medicine world.
A Europe-specific guide to 23 longevity clinics across 8 countries, with our top picks for luxury, diagnostics, value, and therapeutic fasting based on WLC editorial data.
Cleveland Clinic Florida is hosting public longevity panels with cardiologists and oncologists over cocktails. When hospital systems start marketing prevention to consumers, the longevity industry has arrived.
Clinique La Prairie is opening a 52-room health resort at AMAALA, Saudi Arabia's mega wellness destination. Construction photos are circulating on X. Here's what we know and what it signals for the longevity industry.
Eli Lilly signed a $2.75B deal with Insilico Medicine for AI-generated drug candidates targeting age-related diseases. Big Pharma is now investing billions in longevity drug discovery. Here's what it means for clinics and patients.
Fountain Life is expanding from 4 to 7+ US locations in 2026, with new centers in Houston, Miami, and Los Angeles. Here's what the expansion means for the US longevity market and how their model compares.
Niagen Bioscience is partnering with OneSpaWorld to offer pharmaceutical-grade NAD+ IV therapy at 80+ medi-spa clinics on high-end cruise ships starting summer 2026. Is this democratization or dilution of longevity medicine?
A head-to-head comparison of two leading European residential longevity clinics — Progevita in Valencia and Clinique La Prairie in Montreux — covering philosophy, treatments, pricing, and who each one is best for.
Epigenetic age tests are marketed as the ultimate longevity metric. But the same sample can produce a 15-year discrepancy, there are no clinical standards, and better diagnostics exist. Here's what the science actually says.
Buchinger Wilhelmi's 70-year fasting tradition vs Chenot Palace's ultra-luxury detox on Lake Lucerne. We compare the evidence, treatments, pricing, and who each clinic serves best.
Clinique La Prairie (est. 1931, Montreux) and Palazzo Fiuggi (est. 2021, Lazio) both command ultra-luxury positioning. But they differ fundamentally on clinical depth, heritage, and what you're actually paying for.
Fountain Life and Human Longevity Inc. both offer premium diagnostic assessments in the US, but differ on genomic depth, AI integration, pricing model, and geographic reach. A data-driven comparison.
Lanserhof and SHA Wellness Clinic represent two distinct philosophies of luxury longevity medicine in Europe — Austrian Alpine precision vs. Spanish Mediterranean integration. Here's how they compare on treatments, pricing, and experience.
Mayo Clinic and Cleveland Clinic both offer elite executive health programs with institutional credibility no startup can match. We compare their diagnostics, specialties, pricing, and how they fit into the longevity clinic landscape.
NAD+ therapy is the most-requested treatment at longevity clinics. But should you get an IV infusion or take oral NMN/NR? We break down the science, dosing, costs, and which clinics offer what.
Progevita and Lanserhof both offer residential longevity programs in Europe, but diverge sharply on treatment range, pricing, and philosophy. A data-driven comparison to help you decide.
Both are residential longevity clinics on Spain's Mediterranean coast. But Progevita and SHA Wellness Clinic differ sharply on philosophy, treatment range, pricing, and who they serve. A head-to-head comparison.
Joe Rogan underwent plasmapheresis at Ways2Well in Austin, calling it 'changing the oil in your body.' The FDA-approved procedure is gaining traction in longevity clinics. Here's what it is, the evidence, costs, and whether it's right for you.
Senolytics promised to extend healthspan by clearing senescent cells. But recent clinical trial setbacks have cooled the hype. Here's the real state of the field in 2026: which companies are advancing, what failed, what clinics offer, and what the science actually supports.
We analyzed 55 longevity clinics across 18 countries on diagnostics, treatments, evidence basis, and accessibility. Here's the definitive 2026 ranking — no affiliate deals, no sponsored placements.
With FDA peptide reclassification restoring access to 14 key peptides, longevity clinics offering peptide therapy are seeing renewed interest. Here's what to look for in a peptide clinic, which peptides are commonly offered, and how to evaluate quality and safety.
HHS Secretary Kennedy announced ~14 peptides will move from Category 2 (restricted) to Category 1 (legal for compounding). Here's what the reclassification means for longevity medicine, which peptides are returning, and why physician oversight matters more than ever.
Stem cell therapy for aging jumped from $29.9B (2025) to $31.8B (2026), with allogeneic MSCs dominating. But which clinics offer the best programs? This guide compares top destinations by cell type, protocol, safety, and cost.
Therapeutic plasma exchange (TPE) is having its moment: Joe Rogan tried it, longevity clinics are adding it to their menus, and a Buck Institute trial showed 2.6-year biological age reduction. But what is it, what does the science say, and where can you actually get it?
UT Health San Antonio launches a National Institute on Aging-funded rapamycin trial with 84 older adults—one of the largest longevity-focused clinical studies to date. The shift: from off-label speculation to evidence-based dosing.
Human Longevity Inc. partners with LEV Foundation to study blood from centenarians and supercentenarians using multi-omic analysis — seeking biomarkers that explain why some people age far more slowly.
The LA Times maps how Southern California has become a longevity industry hub — where biotech labs, venture capital, AI diagnostics, and concierge medicine are converging around healthspan extension.
A sector maturity signal: less hype, more real medicine — protocols, traceability, and clinical oversight.
A critical analysis of the 'longevity clinic' phenomenon: serious prevention and offerings with limited evidence coexist. The challenge is separating signal from noise.
The U.S. government's ARPA-H launches the PROSPR program: $144M over five years to identify early aging biomarkers and run the first clinical trials explicitly aimed at extending healthy lifespan.
A clinic announces a longevity program focused on men: coordinated assessment + roadmap + follow-up. A signal of the sector's 'productization.'
BBC examines the longevity industry boom: extreme diagnostics, expensive programs, and the key question — what part is real prevention and what part is marketing?
Cleveland Clinic becomes Official Healthcare Provider of the PGA TOUR through 2032: clinical integration in the Player Performance Center, sports medicine, and athletic longevity.
A sharp critique of 'longevity marketing': the future is measurable prevention, clear boundaries, and fewer interventions without robust evidence.
An Am Law 100 firm launches a group dedicated to longevity/healthspan: a signal that regulation, privacy, and IP are becoming the real battleground.
The Washington Post investigates the longevity medicine boom — from biohacking expos to high-end clinics — finding that commercial fervor has outpaced both scientific evidence and federal regulation.
An inside look at Biograph: 6 hours, 30+ tests, and 1,000+ data points. The clinical question isn't 'what do you measure' — it's what decisions you change with the data.
A comprehensive review of 2025's longevity milestones: AI-driven drug deals, clinic proliferation, biomarker standardization, and the XPRIZE Healthspan competition reaching its final phase.
The EMA publishes its quarterly ATMP report (Jun–Nov 2025): cell, gene, and tissue therapy. A key regulatory signal for clinics offering stem cells or regenerative therapies.
A new franchise concept of 'longevity studios' blends recovery therapies (red light, HBOT, cold plunge) with clinical upsells (biomarkers, NAD, GLP-1, HRT, peptides, IV).
A Cell Stem Cell study shows that correcting lysosomal dysfunction in aged mouse blood stem cells restores their regenerative capacity eightfold. Significant, but not a clinic treatment yet.
Longevity.Technology launches Longevity Clinics World, a directory of 350+ pre-validated clinics globally. The move signals an industry maturing from niche to mainstream.
An editorial in Aging by its Editor-in-Chief reviews the rapid rise of longevity clinics worldwide, highlighting both their potential for data-driven innovation and the serious risks of cost, standardization gaps, and scientific disconnect.
A systematic review in Nature Metabolism concludes that clinical evidence for NAD+ supplementation in humans remains scarce and results are heterogeneous. More research needed.
Forbes identifies longevity clinics and medical tourism as the dominant wellness trend of 2025 — with biological age testing, epigenetic profiling, and destination diagnostics driving a new category.